BR9905648A - Mediador de androgênio oticamente puro - Google Patents

Mediador de androgênio oticamente puro

Info

Publication number
BR9905648A
BR9905648A BR9905648-8A BR9905648A BR9905648A BR 9905648 A BR9905648 A BR 9905648A BR 9905648 A BR9905648 A BR 9905648A BR 9905648 A BR9905648 A BR 9905648A
Authority
BR
Brazil
Prior art keywords
mediator
optically pure
pure androgen
androgen
stereoisomer
Prior art date
Application number
BR9905648-8A
Other languages
English (en)
Inventor
Thomas George Gant
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9905648A publication Critical patent/BR9905648A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Abstract

Processo de Invenção: <B> "MEDIADOR DE ANDROGêNIO OTICAMENTE PURO".<D> Esta invenção refere-se a um mediador de androgênio oticamente puro, a composições farmacêuticas contendo o estereoisómero e a utilização do estereoisómero para ajudar na prevenção e restabelecimento de, por exemplo, declínio na massa e força muscular relacionado com a idade e no tratamento de condições que se apresentam com baixa massa óssea em mamíferos, incluindo ser humanos.
BR9905648-8A 1998-11-20 1999-11-18 Mediador de androgênio oticamente puro BR9905648A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10927798P 1998-11-20 1998-11-20

Publications (1)

Publication Number Publication Date
BR9905648A true BR9905648A (pt) 2001-03-20

Family

ID=22326804

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9905648-8A BR9905648A (pt) 1998-11-20 1999-11-18 Mediador de androgênio oticamente puro

Country Status (5)

Country Link
US (1) US6083956A (pt)
EP (1) EP1002799A1 (pt)
JP (1) JP3294574B2 (pt)
BR (1) BR9905648A (pt)
CA (1) CA2290332C (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020107230A1 (en) * 2000-12-22 2002-08-08 Waldon R. Forrest Methods and formulations for the treatment of female sexual dysfunction
FR2825268B1 (fr) * 2001-05-31 2004-09-17 Oreal Composition cosmetique comprenant des particules de carbonate de calcium et des agents de conditionnement
EP1439841B1 (en) * 2001-10-19 2007-09-19 Merck & Co., Inc. Androgen receptor modulators and methods of use thereof
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688808A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods

Also Published As

Publication number Publication date
EP1002799A1 (en) 2000-05-24
JP2000159771A (ja) 2000-06-13
CA2290332A1 (en) 2000-05-20
CA2290332C (en) 2003-11-11
US6083956A (en) 2000-07-04
JP3294574B2 (ja) 2002-06-24

Similar Documents

Publication Publication Date Title
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
BR9804437A (pt) Compostos para a osteoporose
BR9714155A (pt) Prevenção da perda e reposição da massa óssea por certos agonistas de prostaglandina.
BR0016058A (pt) Compostos de fosfonato
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
AP9801269A0 (en) Prostaglandin agonists.
BR9910570A (pt) Aparelho para o tratamento de distúrbios de tecido e/ou das juntas
BR9712285A (pt) Tetrafosfonato bicìclico de trianidridas
BR9913156A (pt) Composição e processo para condicionamento, clareamento e realce do cabelo
BR9812837A (pt) Processo para fazer um composto, e, composto
GT199700009AA (es) Terapia combinada para la osteoporosis
BR0211011A (pt) Composição, método para fornecimento de estabilidade fìsica, método para tratamento de fibras queratìnicas e kit de múltiplos compartimentos
BR9713574A (pt) Processo para a desinfecção de instrumentos.
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
BR9905648A (pt) Mediador de androgênio oticamente puro
BR9811643A (pt) Suplementação quìmica de osso
BR9808923A (pt) Composto, e, processo para fazer o mesmo
EE200000163A (et) Protsess kirurgiliste instrumentide puhastamiseks
BR9807265A (pt) Processo de epoxidação seletiva para preparação de compostos farmacêuticos
PT1077606E (pt) Processo para a preparacao de uma composicao antimicrobiana
PT89303A (pt) Processo para a preparacao de tienotriciclos e de composicoes farmaceuticas que os contem
BR9911943A (pt) Composições compreendendo análogos gaba e um descongestionante para aliviar dor de cabeça de sino
BR9911770A (pt) Processo para a preparação estereoquimicamente controlada de compostos azacìclicos com elevado grau de substituição, isomericamente puros
BR9906931A (pt) Triazepinonas, processo para sua preparação e sua aplicação terapêutica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DA(S) 8A E 9A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 1986 DE 27/03/2009.